Cheng-Han Chou

Title: Innovations and Contributions of Cheng-Han Chou

Introduction

Cheng-Han Chou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target tumor microenvironments. With a total of four patents to his name, his work focuses on innovative approaches to cancer treatment.

Latest Patents

Chou's latest patents include groundbreaking research on histone deacetylase inhibitors for immunomodulation in tumor microenvironments. This patent discusses compounds that are class I HDAC inhibitors, which possess epigenetic immunomodulatory activities that inhibit the growth of tumor cells. Another notable patent is the anticancer combination of chidamide and celecoxib salts. This invention relates to a combination of a histone deacetylase (HDAC) inhibitor, chidamide in an acidic salt form, and a nonsteroidal anti-inflammatory drug (NSAID), celecoxib in a basic salt form. This combination significantly regulates the tumor microenvironment and dramatically improves anti-cancer activity.

Career Highlights

Cheng-Han Chou has worked with notable companies such as Great Novel Therapeutics Biotech & Medicals Corporation and Far Eastern New Century Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of cancer research.

Collaborations

Chou has collaborated with esteemed colleagues, including Jia-Shiong Chen and Mu-Hsuan Yang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Cheng-Han Chou's contributions to biotechnology and cancer treatment through his innovative patents highlight his role as a leading inventor in his field. His work continues to pave the way for advancements in cancer therapies.